grant
Prion Disease Therapeutics
Organization NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESLocation UNITED STATES
NIHUS FederalResearch GrantFY2025AD dementiaAddressAlzheimer Type DementiaAlzheimer disease dementiaAlzheimer sclerosisAlzheimer syndromeAlzheimer'sAlzheimer's DiseaseAlzheimers DementiaAssayBindingBioassayBiological AssayCatalytic CoreCatalytic DomainCatalytic RegionCatalytic SiteCatalytic SubunitDegenerative Neurologic DisordersDevelopmentDiseaseDisorderDrugsFailureGoalsLeadMT-bound tauMachine LearningMedicationMolecular InteractionNervous System Degenerative DiseasesNeural Degenerative DiseasesNeural degenerative DisordersNeurodegenerative DiseasesNeurodegenerative DisordersNeurologic Degenerative ConditionsPathologicPb elementPharmaceutical PreparationsPrimary Senile Degenerative DementiaPrion DiseasesPrion Protein DiseasesPrion-Induced DisorderProcessProliferatingStructureSurfaceTauopathiesTestingTherapeuticToxic effectToxicitiesTransmissible DementiasTransmissible Spongiform EncephalopathiesTraumatic encephalopathyUniversitiesabnormally aggregated tau proteinchronic traumatic encephalopathycostdegenerative diseases of motor and sensory neuronsdegenerative neurological diseasesdevelopmentaldrug discoverydrug/agenteffective therapyeffective treatmentfilamentous tau inclusionheavy metal Pbheavy metal leadinhibitorinsoluble aggregatemachine based learningmachine learning based methodmachine learning methodmachine learning methodologiesmicrotubule associated protein tau aggregationmicrotubule associated protein tau depositmicrotubule bound taumicrotubule-bound tauneurodegenerative illnessneuropathologic tauneuropathological taupaired helical filament of tauprimary degenerative dementiaprion disorderprotein aggregateprotein aggregationself-aggregate tausenile dementia of the Alzheimer typesmall molecular inhibitorsmall molecule inhibitorspongiform degenerationspongiform encephalopathysynucleinopathytautau PHFtau Proteinstau accumulationtau aggregatetau aggregationtau associated neurodegenerationtau associated neurodegenerative processtau driven neurodegenerationtau factortau fibrillizationtau filamenttau induced degenerationtau induced neurodegenerationtau mediated neurodegenerationtau neurodegenerative diseasetau neurofibrillary tangletau neuropathologytau oligomertau paired helical filamenttau pathologytau pathophysiologytau polymerizationtau proteinopathytau related neurodegenerationtau-induced pathologytau-tau interactiontauopathic neurodegenerative disordertauopathyτ Proteinsτ aggregation
Description preview
Therapeutics for tauopathies such as Alzheimer's disease and chronic traumatic encephalopathy are sorely needed. Machine learning methods hold the promise to reduce the costs and the failure rates of conventional drug discovery pipelines. This issue is especially pressing for neurodegenerative diseases, where the development of disease-modifying…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click